strategic-management

256 MERNOUSH BANTON
EXHIBIT 5 Merck & Company Balance Sheet
Annual Data (all numbers in thousands)
PERIOD ENDING 31-Dec-08 31-Dec-07 31-Dec-06
Assets
Current Assets
Cash and Cash Equivalents $4,368,300 5,336,100 5,914,700
Short Term Investments 1,118,100 2,894,700 2,798,300
Net Receivables 11,535,200 3,636,200 3,314,800
Inventory 2,283,300 1,881,000 1,769,400
Other Current Assets — 1,297,400 1,433,000
Total Current Assets 19,304,900 15,045,400 15,230,200
Long Term Investments 6,491,300 7,159,200 7,788,200
Property Plant and Equipment 11,999,600 12,346,000 13,194,100
Goodwill 1,438,700 1,454,800 1,431,600
Intangible Assets 525,400 713,200 943,900
Accumulated Amortization — — —
Other Assets 7,435,800 11,632,100 5,981,800
Deferred Long Term Asset Charges — — —
Total Assets 47,195,700 48,350,700 44,569,800
Liabilities
Current Liabilities
Accounts Payable 12,021,600 10,434,600 11,437,600
Short/Current Long Term Debt 2,297,100 1,823,600 1,285,100
Other Current Liabilities — — —
Total Current Liabilities 14,318,700 12,258,200 12,722,700
Long Term Debt 3,943,300 3,915,800 5,551,000
Other Liabilities — — —
Deferred Long Term Liability Charges 7,766,600 11,585,300 6,330,300
Minority Interest 2,408,800 2,406,700 2,406,100
Negative Goodwill — — —
Total Liabilities $28,437,400 30,166,000 27,010,100
Stockholders’ Equity
Misc Stocks Options Warrants — — —
Redeemable Preferred Stock — — —
Preferred Stock — — —
Common Stock 29,800 29,800 29,800
Retained Earnings 43,698,800 39,140,800 39,095,100
Treasury Stock (30,735,500) (28,174,700) (27,567,400)
Capital Surplus 8,319,100 8,014,900 7,166,500
Other Stockholders’ Equity (2,553,900) (826,100) (1,164,300)
Total Stockholders’ Equity 18,758,300 18,184,700 17,559,700
Total Liabilities and SE $47,195,700 48,350,700 44,569,800
Source: Merck’s 2008 Form 10K.